Thursday, 5th December 2019



Prof. Olivier Schwartz

Instituto Pasteur

París, Francia






2015 04 10 oliivier schwartz minOlivier Schwartz estudió farmacia en la Universidad de París VI y obtuvo el Doctorado (en virología) por la Universidad de París VII en 1993. Realizó su trabajo predoctoral y postdoctoral en el Instituto Pasteur de la misma ciudad, donde investigó sobre el paper de la proteína Nef del virus de la inmunodeficiencia humana tipo 1 (VIH-1) en la patogénesis vírica. En 1995 fue nombrado científico de plantilla del Instituto Pasteur, donde fue asignado a la Unidad de Retrovirus y Transferencia Genética, y posteriormente promocionado a Profesor Asociado en 2001. Desde 2007, el Prof. Schwartz dirige la Unidad de “Virus e Inmunidad” del Instituto Pasteur. Ha sido presidente del Comité Científico del Instituto (2009-2011) y director de su Departamento de Virología (2012-2014). Olivier Schwartz ha recibido premios de investigación de varias instituciones francesas y en 2008 fue elegido miembro de la Organización Europea de Biología Molecular (EMBO).

Actualmente, Olivier Schwartz está interesado en el estudio de los procesos biológicos implicados en la propagación del VIH y del virus causante del chikunguña, así como las respuestas inmunes causadas por estos virus. El VIH es un patógeno bien conocido, mientras que el chikunguña es una enfermedad caracterizada por fiebre y dolores musculares y en las articulaciones, cuya causa se debe a la infección por un virus transmitido por mosquitos del género Aedes. El profesor Schwartz ha publicado más de 130 trabajos en revistas científicas sobre temas diversos relacionados con la patogénesis viral (la mayoría sobre el VIH). Sus trabajos más recientes tratan sobre el papel antiviral de la proteína celular SAMHD1, y su influencia en la transmisión de virus célula-célula, así como los mecanismos por los que los virus pueden contrarrestar este efecto (véanse referencias abajo citadas). En su presentación en el CBMSO, el Prof. Schwartz nos dará una visión amplia de las investigaciones llevadas a cabo actualmente en su laboratorio, incluyendo otros mecanismos de control de la transmisión célula-célula del VIH.

(Más información: Dr. Luis Menéndez Arias, This email address is being protected from spambots. You need JavaScript enabled to view it.)



Olivier Schwartz studied pharmacy at the University of Paris VI, and obtained a Ph.D. in virology at the University of Paris VII in 1993. He was a pre-doctoral and post-doctoral fellow at the Pasteur Institute where he studied the role of the HIV-1 Nef protein in viral pathogenesis. In 1995 he became a staff scientist in the Retrovirus and Genetic Transfer Unit of the Pasteur Institute, and was later promoted to Associate Professor in 2001. Since 2007, Prof. Schwartz is head of the “Virus and Immunity Unit” of the Pasteur Institute. Besides, he has been president of its Scientific Council (2009-2011) and director of the Virology Department (2012-2014). He has received several research awards from French organizations and in 2008 he was elected member of the European Molecular Biology Organization (EMBO).

Olivier Schwartz is currently interested in studying the mechanisms and biological processes involved in HIV and Chikungunya virus replication, and the host innate and adaptive immune responses induced by these viruses. HIV is a well-known pathogen while Chikungunya is a disease characterized by fever, rash, muscle aches and joint pain that is caused by a mosquito-borne virus belonging to the family of the alphaviruses. Prof. Schwartz has published over 130 peer-reviewed research articles on diverse topics mainly related to HIV-1 pathogenesis. His recent work has been devoted to studies on the role of SAMHD1, a host factor that restricts HIV-1 cell-to-cell transmission, and mechanisms by which viruses can overcome this block (see references below). In addition, he has studied how interferon and other factors could regulate cell-to-cell transmission. In his presentation at the CBMSO, Prof. Schwartz will give us a broad overview of the research currently carried out in his laboratory.

(More information: Dr. Luis Menéndez Arias, This email address is being protected from spambots. You need JavaScript enabled to view it.)


Publicaciones seleccionadas / Selected publications:

  • Chauveau L, Puigdomenech I, Ayinde D, Roesch F, Porrot F, Bruni D, Visseaux B, Descamps D, Schwartz O. 2015. HIV-2 Infects resting CD4+ T cells but not monocyte-derived dendritic cells. Retrovirology, January 13, 2015
  • Compton A, Bruel T, Porrot F, Mallet A, Sachse M, Euvrard M, Liang C, Casartelli N, Schwartz O. 2014. IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread. Cell Host and Microbe 16, 736-747, December 10, 2014
  • Roesch, F. Schwartz, O. (2013). The SAMHD1 knockout mouse model : in vivo veritas ?. EMBO journal 32:2427-2429
  • Ayinde, D. Casartelli, N. Schwartz, O. (2012). Restricting HIV the SAMHD1 way : through nucleotide starvation. Nature Review Microbiology, Oct, 10 (10):675-80 (Epub 2012 Aug 28)
  • Laguette, N. Sobhian, B. Casartelli, N. Ringeard, M. Chable-Bessia, C. Ségéral, E. Yatim, A. Emiliani, S. Schwartz, O and Benkirane, M. (2011) Samhd1 is a dendritic cell HIV-1 restriction factor counteracted by Vpx. Nature, May, 25

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand


What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: